Melisron Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was ILS 1,424 million compared to ILS 1,115 million a year ago. Net income was ILS 1,473 million compared to net loss of ILS 250 million a year ago.

Basic earnings per share from continuing operations was ILS 31.06 compared to basic loss per share from continuing operations of ILS 5.26 a year ago. Diluted earnings per share from continuing operations was ILS 31.06 compared to diluted loss per share from continuing operations of ILS 5.26 a year ago.